ioneer Ltd

Waymo Pioneer Sebastian Thrun Is Quietly Building a New Robotics Startup

Sebastian Thrun is developing Dulo, a stealth robotics startup focused on hardware design and faster manufacturing.

Strategus Celebrates Ninth Consecutive Year on the Inc. 5000 List, the Most Prestigious Ranking of America’s Fastest-Growing Private Companies for 2026

Recognition reflects Strategus' successful evolution into a full service programmatic advertising partner focused on delivering measurable business resultsDENVER, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Strategus today announced that it has been named to the 2026 Inc. 5000 list, marking its ninth consecutive year among America’s fastest growing private companies. Built on a decade of CTV leadership–including pioneering the first programmatic CTV campaign in 2015–Strategus has evolved into a full-servi

VR Pioneer, Anduril Co-Founder Palmer Luckey Urges SSC Guardians to Adopt ‘Founders Mindse

Why Archer Aviation Stock Soared Today

The air taxi pioneer is making a game-changing acquisition.

Outset Medical Reports Second Quarter 2026 Results

SAN JOSE, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today reported financial results for the second quarter ended June 30, 2026. Second Quarter and Recent Highlights Net revenue totaled $31.6 million, an increase of 1% compared to the prior-year period and an increase of 14% sequentially.Recurring revenue, consisting of

AI Trailblazers Nvidia, Palantir, Alphabet, and Meta Are Shaking Wall Street to Its Core With This $3.4 Billion Warning

The people who know these AI pioneers best are sending a worrisome message.

News - Space Reconnaissance Pioneers visit VSFB

Contineum Therapeutics Reports Second-Quarter 2026 Financial Results; Affirms Key Clinical Development Milestones

SAN DIEGO, July 30, 2026--Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated small molecule therapies for inflammatory and fibrotic diseases with significant unmet need, today reported its second-quarter 2026 financial results and affirmed its key clinical development milestones.

J&J nabs option to buy ‘in vivo’ CAR-T maker Sail for nearly $2.6B

The deal with the buzzy Flagship Pioneering-backed startup makes J&J the latest large drugmaker to bet that the technology might be able to treat autoimmune conditions.

Tesla (TSLA) Reports Q2: Everything You Need To Know Ahead Of Earnings

Electric vehicle pioneer Tesla (NASDAQ:TSLA) will be reporting earnings this Wednesday after market close. Here’s what to expect.